Hongliang Zhang
Lishui, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Role of IL-32 in RA pathology and potential as a drug target.
Journal: Frontiers in immunology
Published: August 31, 2025
Reprogramming the tumor microenvironment: synergistic mechanisms of antibody-drug conjugates and immune checkpoint inhibitors.
Journal: Antibody therapeutics
Published: June 10, 2025
Huoxiang-Shihu herbal formula attenuates alcoholic-induced gastric injury by regulating the HIF-1α/VEGF pathway and inhibiting oxidative stress.
Journal: Journal of ethnopharmacology
Published: May 29, 2025
Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities.
Journal: Frontiers in cell and developmental biology
Published: April 28, 2025
Targeting inflammasomes as a therapeutic potential for HIV/AIDS.
Journal: Cellular and molecular life sciences : CMLS
Published: February 21, 2025
When glycobiology meets inflammasome activation: Insights and implications.
Journal: Journal of advanced research
Published: February 12, 2025
Resolution of inflammation during rheumatoid arthritis.
Journal: Frontiers in cell and developmental biology
Published: January 06, 2025
NLRP3 inflammasome: From drug target to drug discovery.
Journal: Drug discovery today
Published: December 02, 2024
ErbB/HER family in cancer immunology: therapeutic advances and mechanisms.
Journal: Drug discovery today
Published: December 02, 2024
Current Situation of Goose Astrovirus in China: A Review.
Journal: Viruses
Published: November 23, 2024
Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application.
Journal: Journal of medical virology
Published: October 24, 2024
Impact of the gut microbiota-Th17 cell axis on inflammatory depression.
Journal: Frontiers in psychiatry
Published: October 10, 2024
Last Updated: 09/26/2026